In recent trading session, Bristol-Myers Squibb Co. (NYSE:BMY) saw 1.82 million shares changing hands at last check today with its beta currently measuring 0.38. Company’s recent per share price level of $52.24 trading at $0.65 or 1.25% at last check today assigns it a market valuation of $105.63B. That most recent trading price of BMY’s stock is at a discount of -36.05% from its 52-week high price of $71.07 and is indicating a premium of 8.92% from its 52-week low price of $47.58. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 26.96 million shares which gives us an average trading volume of 16.97 million if we extend that period to 3-months.
Bristol-Myers Squibb Co. (NYSE:BMY) trade information
Upright in the green today for gaining 1.25%, in the last five days BMY remained trading in the red while hitting it’s week-highest on Monday, 03/18/24 when the stock touched $52.24 price level, adding 0.87% to its value on the day. Bristol-Myers Squibb Co.’s shares saw a change of 1.80% in year-to-date performance and have moved -0.20% in past 5-day. Bristol-Myers Squibb Co. (NYSE:BMY) showed a performance of 1.76% in past 30-days. Number of shares sold short was 32.65 million shares which calculate 2.24 days to cover the short interests.
Bristol-Myers Squibb Co. (BMY) estimates and forecasts
Statistics highlight that Bristol-Myers Squibb Co. is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -11.59% of value to its shares in past 6 months, showing an annual growth rate of -11.98% while that of industry is 12.00. Apart from that, the company came lowering its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to decrease by -22.90% in the current quarter and calculating 1.10% increase in the next quarter. This year revenue growth is estimated to rise 2.10% from the last financial year’s standing.
13 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $11.43 billion for the same. And 13 analysts are in estimates of company making revenue of $11.53 billion in the next quarter that will end on Jun 2024.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 5.14% during past 5 years. In 2024, company’s earnings growth rate is likely to be around -9.40% while estimates for its earnings growth in next 5 years are of -2.80%.
BMY Dividends
Bristol-Myers Squibb Co. is more likely to be releasing its next quarterly report on April 25 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Bristol-Myers Squibb Co. (NYSE:BMY)’s Major holders
Insiders are in possession of 0.10% of company’s total shares while institution are holding 79.18 percent of that, with stock having share float percentage of 79.25%. Investors also watch the number of corporate investors in a company very closely, which is 79.18% institutions for Bristol-Myers Squibb Co. that are currently holding shares of the company. Vanguard Group Inc is the top institutional holder at BMY for having 198.16 million shares of worth $10.35 billion. And as of Dec 30, 2023, it was holding 9.78% of the company’s outstanding shares.
The second largest institutional holder is Blackrock Inc., which was holding about 168.1 million shares on Dec 30, 2023. The number of shares represents firm’s hold over 8.29% of outstanding shares, having a total worth of $8.78 billion.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 30, 2023, the former fund manager was holding 63.87 million shares of worth $3.34 billion or 3.15% of the total outstanding shares. The later fund manager was in possession of 49.7 million shares on Dec 30, 2023, making its stake of worth around $2.6 billion in the company or a holder of 2.45% of company’s stock.
